COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.620175/full |
_version_ | 1818575940974804992 |
---|---|
author | Nicole F. Clark Nicole F. Clark Andrew W. Taylor-Robinson Andrew W. Taylor-Robinson |
author_facet | Nicole F. Clark Nicole F. Clark Andrew W. Taylor-Robinson Andrew W. Taylor-Robinson |
author_sort | Nicole F. Clark |
collection | DOAJ |
first_indexed | 2024-12-15T00:47:43Z |
format | Article |
id | doaj.art-6b70996a1dff437d95cc9d32e8d639da |
institution | Directory Open Access Journal |
issn | 2296-858X |
language | English |
last_indexed | 2024-12-15T00:47:43Z |
publishDate | 2021-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Medicine |
spelling | doaj.art-6b70996a1dff437d95cc9d32e8d639da2022-12-21T22:41:30ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-03-01810.3389/fmed.2021.620175620175COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?Nicole F. Clark0Nicole F. Clark1Andrew W. Taylor-Robinson2Andrew W. Taylor-Robinson3Institute for Applied Ecology, University of Canberra, Bruce, ACT, AustraliaCentre for Marine Bioproducts Development, College of Medicine and Public Health, Flinders University, Bedford Park, SA, AustraliaInfectious Diseases Research Group, School of Health, Medical and Applied Sciences, Central Queensland University, Brisbane, QLD, AustraliaCollege of Health and Human Sciences, Charles Darwin University, Casuarina, NT, Australiahttps://www.frontiersin.org/articles/10.3389/fmed.2021.620175/fullchlorophylltherapylymphopeniaSARS-CoV-2COVID-19coronavirus |
spellingShingle | Nicole F. Clark Nicole F. Clark Andrew W. Taylor-Robinson Andrew W. Taylor-Robinson COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? Frontiers in Medicine chlorophyll therapy lymphopenia SARS-CoV-2 COVID-19 coronavirus |
title | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
title_full | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
title_fullStr | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
title_full_unstemmed | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
title_short | COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection? |
title_sort | covid 19 therapy could a copper derivative of chlorophyll a be used to treat lymphopenia associated with severe symptoms of sars cov 2 infection |
topic | chlorophyll therapy lymphopenia SARS-CoV-2 COVID-19 coronavirus |
url | https://www.frontiersin.org/articles/10.3389/fmed.2021.620175/full |
work_keys_str_mv | AT nicolefclark covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection AT nicolefclark covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection AT andrewwtaylorrobinson covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection AT andrewwtaylorrobinson covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection |